Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Daiichi"


25 mentions found


Explainer: The Fukushima water release plan
  + stars: | 2023-08-22 | by ( ) www.reuters.com   time to read: +5 min
An aerial view shows the storage tanks for treated water at the tsunami-crippled Fukushima Daiichi nuclear power plant in Okuma town, Fukushima prefecture, Japan August 22, 2023, in this photo taken by Kyodo. Water containing tritium is routinely released from nuclear plants around the world, and regulatory authorities support dealing with the Fukushima water in this way. When ingested at levels above those in the released water it can raise cancer risks, a Scientific American article said in 2014. SAFETYJapan and scientific organisations say the released water is safe, but environmental activists argue that all the possible impacts have not been studied. The latest import restrictions were imposed in July after the IAEA approved Japan's plans to discharge the treated water.
Persons: Masanobu Sakamoto, Katya Golubkova Organizations: Kyodo, REUTERS Acquire, Rights, Tanks, Electric Power Company, Tepco, International Atomic Energy Agency, IAEA, Greenpeace, World Health Organization, South, National Federation of Fisheries Cooperative Associations, Tokyo, Thomson Locations: Okuma, Fukushima prefecture, Japan, Fukushima, China
An aerial view shows the storage tanks for treated water at the tsunami-crippled Fukushima Daiichi nuclear power plant in Okuma town, Fukushima prefecture, Japan August 22, 2023, in this photo taken by Kyodo. Mandatory credit Kyodo via REUTERS Acquire Licensing RightsSEOUL, Aug 22 (Reuters) - South Korea said on Tuesday it sees no problem with the scientific or technical aspects of Japan's plan to release water from the wrecked Fukushima nuclear power plant but it does not necessarily support the plan. "We have assessed that there are no scientific or technical problems with the plan to release the contaminated water," it said. "But we want to make clear that our government does not necessarily agree with or support the plan to release contaminated water," the statement said. The country's opposition Democratic Party, however, said on Tuesday that its "battle" to stop the release would continue, calling Japan's plan "selfish and irresponsible."
Persons: Yoon Suk Yeol, Jack Kim, Hyonhee, Christian Schmollinger Organizations: Kyodo, REUTERS Acquire, Rights, South, Democratic Party, Thomson Locations: Okuma, Fukushima prefecture, Japan, Rights SEOUL, South Korea, Seoul
Nuclear power has been touted as a proven, safe way of producing clean energy, but why isn't it more widely adopted? Schroders noted that nuclear power is not only scalable, but much cleaner — emitting just 10-15 grams of CO2 equivalent per kilowatt hour. That's the reason why nations are having a second look at nuclear power, Shellenberger said. A report by global campaigning network Greenpeace in March 2022 was of the position that besides the commonly held concern of nuclear safety, nuclear energy is too expensive and too slow to deploy compared to other renewables. Greenpeace acknowledged that "all in all, nuclear power stations score comparable with wind and solar energy."
Persons: Sean Gallup, Michael Shellenberger, Schroders, Shellenberger, we're, CNBC's, Adam Fleck, hasn't, Fleck Organizations: Getty, Greenpeace, CNBC, Governments, International Energy Agency, Soviet Union Locations: U.S, Ukraine, Fukushima, Japan
Japan to release Fukushima water into ocean starting this week
  + stars: | 2023-08-22 | by ( ) www.cnbc.com   time to read: +1 min
Fisherman Haruo Ono stands on one of his fishing boats at Tsurushihama Fishing Port, Shinchi-machi of Fukushima Prefecture, some 60 kms north of the crippled Fukushima Daiichi nuclear plant on August 21, 2023, ahead of a government's plan to begin releasing treated water from the plant into the Pacific Ocean. Philip Fong | Afp | Getty ImagesJapan said on Tuesday it will start releasing more than 1 million metric tonnes of treated radioactive water from the wrecked Fukushima nuclear power plant on Aug. 24, putting into motion a plan that has drawn strong criticism from China. Japan has said that the water release is safe. Still, some neighboring countries have expressed skepticism over the safety of the plan, with Beijing emerging as the biggest critic. Foreign ministry spokesman Wang Wenbin said in July that Japan had shown selfishness and arrogance, and had not fully consulted the international community about the water release.
Persons: Ono, Philip Fong, Fumio Kishida, Wang Wenbin Organizations: Afp, Getty, Japan, Tokyo Electric Power Company, Nuclear, Authority, International Atomic Energy Agency Locations: Shinchi, Fukushima Prefecture, China, Japan, Beijing
At a busy intersection in Seoul this summer, a banner from the main opposition Democratic Party barked “No!” to Japan’s plan to dump treated radioactive water from its destroyed Fukushima nuclear power plant into the Pacific. ​Across the street, a placard from the governing People Power Party said the real threat was the opposition spreading conspiracy theories that would scare people away from seafood: “The Democratic Party is killing the livelihoods of our fishermen!”Japan’s imminent decision to release more than 1.3 million tons of ​treated water at Fukushima Daiichi, the power plant that was destroyed by an earthquake and tsunami in 2011, has raised alarms across the​ Pacific. But in South Korea, it has triggered a particularly raucous political debate, with the government of President Yoon Suk Yeol and its enemies slugging it out through banners, YouTube videos, news conferences and protests. ​What sets South Korea apart from other critics in the region is that its government has endorsed Japan’s discharge plan despite widespread public misgiving, only asking Japan to provide transparency to ensure the water is discharged properly. The authorities are running online advertisements and holding daily news briefings to dispel what they call fear-mongering by the opposition and to convince the people that the water will do no harm.
Persons: Democratic Party barked, Yoon Suk Organizations: Democratic Party, People Power Party Locations: Seoul, Fukushima, South Korea, Korea, Japan
Japan PM to meet fishing industry leaders over Fukushima water
  + stars: | 2023-08-21 | by ( ) www.reuters.com   time to read: +2 min
Japan's Prime Minister Fumio Kishida visits the tsunami-crippled Fukushima Daiichi nuclear power plant in Okuma town, Fukushima prefecture, Japan August 20, 2023, in this photo released by Kyodo. Mandatory credit Kyodo via REUTERS Acquire Licensing RightsTOKYO, Aug 21 (Reuters) - Japanese Prime Minister Fumio Kishida will on Monday meet fishing industry representatives in a bid to convince them of the safety of treated radioactive water due to be released from the wrecked Fukushima nuclear power plant into the sea. The water has been treated to remove most radioactive elements except for tritium, a hydrogen isotope that must be diluted because it is difficult to filter. Despite such assurances, the prospect of more than a million tons of water being pumped into the Pacific from the nuclear plant owned by Tokyo Electric Power Company (9501.T) has raised alarm. Japanese Industry Minister Yasutoshi Nishimura is due to meet the same fishing industry leaders before the Kishida meeting.
Persons: Fumio Kishida, Yasutoshi Nishimura, Satoshi Sugiyama, Elaine Lies, Muralikumar Organizations: Japan's, Kyodo, REUTERS Acquire, Rights, International Atomic Energy Agency, IAEA, Tokyo Electric Power Company, Citizens, Japanese Industry, Thomson Locations: Okuma, Fukushima prefecture, Japan, Tokyo, China, South Korea
[1/2] Japan's Prime Minister Fumio Kishida visits the tsunami-crippled Fukushima Daiichi nuclear power plant in Okuma town, Fukushima prefecture, Japan August 20, 2023, in this photo released by Kyodo. Mandatory credit Kyodo via REUTERS Acquire Licensing RightsTOKYO, Aug 20 (Reuters) - Japanese Prime Minister Fumio Kishida said he will meet fishermen as soon as Monday to seek their understanding of the government's plan to release radioactive water from the wrecked Fukushima nuclear plant into the Pacific. He said his government would make every effort to ensure the safety of the water release and counter reputational damage. Releasing the water is a key step in decommissioning the Fukushima Daiichi plant and revitalising Fukushima, he added. The prime minister declined to say when it would begin.
Persons: Fumio Kishida, Kishida, Tom Bateman, Yuka Obayashi, William Mallard Organizations: Japan's, Kyodo, REUTERS Acquire, Rights, Tokyo Electric Power, Tepco, International Atomic Energy Agency, IAEA, Thomson Locations: Okuma, Fukushima prefecture, Japan, South Korea, China
An aerial view shows the Fukushima Daiichi nuclear power plant following a strong earthquake, in Okuma town, Fukushima prefecture, Japan in this photo taken by Kyodo on March 17, 2022. Members of a group that tracks such levels in food and seawater, they fear Japan's plans to release treated radioactive water into the sea near the Fukushima nuclear plant could stir an anxiety among residents reminiscent of the 2011 disaster. "The people of Fukushima endured the risks for the last 12 years and have confirmed the radiation level has dropped," said Ai Kimura, director of non-profit group Mothers' Radiation Lab Fukushima, also known as Tarachine. Japan is preparing this summer to start discharging into the Pacific more than a million tons of water from the tsunami-crippled power plant, but has not yet revealed the date. Reporting by Kiyoshi Takenaka, Akiko Okamoto and Tom Bateman; Editing by Chang-Ran Kim and Clarence FernandezOur Standards: The Thomson Reuters Trust Principles.
Persons: Ai Kimura, Kimura, what's, Kimura's, Kiyoshi Takenaka, Akiko Okamoto, Tom Bateman, Chang, Ran Kim, Clarence Fernandez Organizations: Kyodo, Rights Companies Tokyo Electric Power Company Holdings, Tokyo Electric Power, Thomson Locations: Okuma, Fukushima prefecture, Japan, IWAKI, Fukushima, Iwaki, Pacific, China, Tarachine
TOKYO, July 7 (Reuters) - Japan's nuclear regulator granted approval on Friday for utility Tokyo Electric Power Co (Tepco), which ran the destroyed Fukushima Daiichi nuclear power plant, to start releasing more than a million tonnes of radioactive water. On Tuesday, the global watchdog, the International Atomic Energy Agency (IAEA), said a two-year review showed Japan's plan for the release would have negligible environmental impact. The Japanese regulator's certificate is the final step the utility required to begin the process. Reporting by Elaine Lies; Editing by Clarence FernandezOur Standards: The Thomson Reuters Trust Principles.
Persons: Elaine Lies, Clarence Fernandez Organizations: Tokyo Electric Power Co, International Atomic Energy Agency, IAEA, Thomson Locations: TOKYO
Unit 3 and unit 4 reactor buildings and storage tanks for contaminated water at the Tokyo Electric Power Company (TEPCO) Fukushima Daiichi nuclear power plant in Okuma, Fukushima prefecture. The U.N. nuclear agency gave its endorsement on Tuesday to Japan's planned release of treated radioactive wastewater into the sea from the damaged Fukushima nuclear plant, saying it meets international standards and its environmental and health impact would be negligible. The plan is opposed by groups in South Korea, China and some Pacific Island nations because of safety concerns and political reasons. However, it concluded that the water release as currently planned "will have a negligible radiological impact on people and the environment." Japan's plan and the equipment for the discharge are "in conformity with the agreed international standards and its application," Grossi said.
Persons: Japan's, Rafael Mariano Grossi, Fumio Kishida, Grossi Organizations: Tokyo Electric Power Company, International Atomic Energy Agency Locations: Fukushima, Okuma, South Korea, China, United States, France
TOKYO, July 5 (Reuters) - International Atomic Energy Agency (IAEA) chief Rafael Grossi met residents on Wednesday to assuage concerns over the safety of Japan's plan to release treated radioactive water from the wrecked Fukushima Daiichi nuclear power plant into the ocean. The reality of people, the economy, and social perceptions may be different from the science, he said, acknowledging the fears surrounding the water release. Grossi will visit the wrecked plant on Wednesday, where he will inaugurate an IAEA office on site that will monitor the release of the water, which is expected to take 30 to 40 years. Some neighbouring countries have also raised concerns over the threat to the environment, with Beijing emerging as the biggest critic. The treated water will be diluted to well below internationally approved levels of tritium before being released into the Pacific.
Persons: Rafael Grossi, Nozaki, Grossi, Yoshimasa Hayashi, Fumio Kishida, Sakura Murakami, Chang, Ran Kim, Gerry Doyle Organizations: Atomic Energy Agency, IAEA, Nikkei, Korean, Yomiuri, Pacific, Thomson Locations: TOKYO, Japan, Beijing, East Asia
The water was distilled after being contaminated from contact with fuel rods at the reactor, destroyed in a 2011 earthquake. Tanks on the site now hold about 1.3 million tonnes of radioactive water - enough to fill 500 Olympic-sized swimming pools. Tepco will dilute the water until tritium levels fall below regulatory limits before pumping it into the ocean from the coastal site. Water containing tritium is routinely released from nuclear plants around the world, and regulatory authorities support dealing with the Fukushima water in this way. Fishing unions in Fukushima have urged the government for years not to release the water, arguing it would undo work to restore the damaged reputation of their fisheries.
Persons: Gerry Doyle Organizations: Tanks, Electric Power Company, Tepco, Tokyo, Thomson Locations: TOKYO, Japan, Fukushima, China
Japan to get crucial UN verdict for Fukushima water release
  + stars: | 2023-07-04 | by ( ) www.cnbc.com   time to read: +2 min
Construction site of the unit 5,6 seaside facilities of the Tokyo Electric Power Company's (TEPCO) Fukushima Daiichi nuclear power plant, in Okuma of Fukushima prefecture. Japan is set to receive a report from a U.N. nuclear watchdog on Tuesday approving its plan to release treated radioactive water from the tsunami-wrecked Fukushima plant into the ocean despite fierce resistance from Beijing and some local opposition. Japan has not specified a date to start the water release, which will take 30 to 40 years to complete, pending the IAEA's review and official approval from the national nuclear regulatory body for Tokyo Electric Power . Through its embassy in Japan, Beijing on Tuesday said the IAEA's report cannot be a "pass" for the water release and called for the plan's suspension. Japan maintains the process is safe as it has treated the water — enough to fill 500 Olympic-sized swimming pools — used to cool the fuel rods of the Fukushima plant after it was damaged by the earthquake and tsunami in 2011.
Persons: Rafael Grossi, Fumio Kishida, Yoshimasa Hayashi Organizations: Tokyo Electric Power, International Atomic Energy Agency Locations: Fukushima, Okuma, Fukushima prefecture, Japan, Beijing
July 3 (Reuters) - AstraZeneca (AZN.L) said on Monday an experimental precision drug slowed progression of lung cancer in a late-stage trial, but the company's shares fell as much as 6% as analysts said the benefits may not be as pronounced as hoped. It declined to provide more trial details, saying they would be presented at an as yet undisclosed medical conference. At 0855 GMT, shares in AstraZeneca were down 5.8% at their lowest level in more than three months. Gilead (GILD.O) has pioneered the targeting of TROP2 with an ADC named Trodelvy, approved to treat certain types of breast and bladder cancer. AstraZeneca said that the datopotamab deruxtecan trial would continue as planned to assess the effect of the drug on overall survival of patients, another important efficacy criterion.
Persons: datopotamab, AstraZeneca, British drugmaker, Kelun, Maggie Fick, Ludwig Burger, Sinchita Mitra, Lucy Raitano, Krishna Chandra Eluri, Susan Fenton Organizations: AstraZeneca, Japan's, Merck & Co, Biotech of, Barclays, Thomson Locations: British, Biotech of China, London, Frankfurt, Bengaluru
[1/2] South Korea's Nuclear Safety and Security Commission Chairperson Yoo Guk-hee announce the results of their inspection of Japan's crippled Fukushima nuclear power plant during a press conference at Government Complex Building in Seoul, South Korea. South Korea's inspection team for... Read moreSEOUL, May 31 (Reuters) - South Korean nuclear safety experts who visited Japan's wrecked Fukushima nuclear power plant said on Wednesday that detailed analysis was needed to verify Japan's plan to release tonnes of contaminated water from it into the sea. The Fukushima Daiichi nuclear station, about 220 km (130 miles) northeast of Tokyo, was destroyed by a magnitude 9.0 earthquake and tsunami in 2011, triggering three reactor meltdowns. The 21-member South Korean team had focused during its six-day trip on water purification, transport and release equipment, as well as sampling and analysis facilities. The International Atomic Energy Agency is also conducting a safety review of Japan's plan to release the water.
Persons: Yoo Guk, Japan's, Yoo, Yoon Suk Yeol, Fumio Kishida, Hyonhee Shin, Robert Birsel Organizations: Safety, Security, Nuclear Safety, Security Commission, South Korean, International Atomic Energy Agency, Thomson Locations: Seoul, South Korea, SEOUL, Fukushima, Tokyo, Japan
Developments in cancer research will be in the spotlight as the American Society of Clinical Oncology hosts the world's biggest cancer research conference in Chicago, starting Thursday. The pair has already has won regulatory approval for Enhertu for metastatic HER2-low breast cancer, but the companies are also studying its use in a variety other HER2 tumors in breast cancers. Lilly's drug, Verzenio, is used in high-risk patients with HR-positive HER2-negative breast cancer that is more likely to reoccur and has already breached the patient's lymph nodes. In a research note earlier this month, Guggenheim analyst Seamus Fernandez said Kisqali is already taking market share from Pfizer's Ibrance in metastatic breast cancer. Merck's Keytruda is also being watched for what benefits it could offer early-stage lung cancer patients .
The healthcare sector outperformed in Europe, India and China last month, according to Citi, which named its top picks worldwide. It gave Amylyx a price target of $53, giving it upside of around 88% from current levels. It gave Beam a price target of $60, implying upside of around 67%. Other European picks from Citi include Swiss healthcare company Roche and British pharma and biotech firm AstraZeneca . Asia stocks In Asia, Citi named Japanese pharmaceutical company Daiichi Sankyo , South Korean biotech firm Samsung Biologics and China's Wuxi Biologics as top picks.
May 5 (Reuters) - Japanese Prime Minister Fumio Kishida will be visiting South Korean President Yoon Suk Yeol on Sunday in the latest effort to improve bilateral ties. - Relations between the two North Asian U.S. allies have been strained over disputes dating to Japan's 1910-1945 occupation of Korea. - Relations deteriorated in 2019 when Japan restricted exports of high-tech materials for making chips and display panels to South Korea. - In late March, Japan's trade ministry lifted export curbs to South Korea on the high-tech materials, while South Korea withdrew its complaint filed at the World Trade Organization on Japan's export controls. Under Yoon, South Korea has resumed trilateral military drills and agreed to more intelligence sharing on issues like tracking ballistic missile launches from North Korea.
Ocean currents have since dispersed the contaminated water enough that radioactive Cesium is nearly undetectable in fish from Fukushima prefecture. A year before the 2011 disaster, government data shows Fukushima’s coastal fishing industry landed catches worth around $69 million. At the same time, ground and rainwater have leaked in, creating more radioactive wastewater that now needs to be stored and treated. This isotope is radioactive tritium, and the scientific community is divided on the risk its dissemination carries. He argues TEPCO should build more storage tanks to allow for the decay of the radioactive tritium, which has a half-life of 12.3 years.
Citi is bullish on Merck , saying that the company's drug pipeline is underappreciated by the market. The exclusive license and collaboration agreement for ADC development helps Merck in developing more cancer treatment drugs — and Citi thinks it could rival its competitors' offerings. Citi anticipates further upside for Merck shares from the Inflation Reduction Act. To be sure, Baum noted a key downside risk to his valuation is if the ADC pipeline disappoints. Further risks include lower-than-anticipated value share capture by the company's Melanoma treatment drug Keytruda, and a slowdown in its animal health business.
SEOUL, Feb 16 (Reuters) - The release of waste water from Japan's wrecked Fukushima nuclear power plant would have a negligible effect on South Korean waters, according to a government study published on Thursday. "That change would be too small to detect," an official at the Korea Institute of Ocean Science and Technology said. The analysis comes as South Korea's President Yoon Suk-yeol is seeking to improve relations with Japan after years of tensions. The water release has raised concerns from neighbouring countries, including China and South Korea. The simulation study has "no connection" to normalising relations between South Korea and Japan, said Oh Haeng-nok, an official at South Korea's Ministry of Oceans and Fisheries.
The company also predicted a return to growth in China, one of its key markets, after reporting a second consecutive quarter of growth even as prices remain under pressure. Sales of its best-selling cancer drugs — Tagrisso, Imfinzi and Lynparza — came in just below estimates from Cowen analysts. Sales started to pick up in the second half of 2022 and in the fourth quarter grew by 3% at constant currency rates. Of key interest to investors is the experimental cancer drug, datopotamab deruxtecan, being evaluated in a keenly anticipated late-stage trial involving lung cancer patients. Partner Daiichi Sankyo (4568.T) this month said results of that study have been delayed to the second quarter from the first quarter of 2023.
The Fukushima Dai-ichi Nuclear Power plant after a massive earthquake and subsequent tsunami on March 14, 2011 in Futaba, Japan. DigitalGlobe | Getty ImagesA Japanese court on Wednesday found three former utility company executives not guilty of negligence over the 2011 Fukushima nuclear power plant disaster and the subsequent deaths of more than 40 elderly residents during their forced evacuation. watch nowThe acquittal disappointed and angered dozens of Fukushima residents and their supporters who attended the ruling or rallied outside the court. It's so irresponsible," said Yuichi Kaido, a lawyer representing the Fukushima residents. The Supreme Court in June, however, said the disaster was unforeseeable and dismissed compensation demands by thousands of residents.
Japan turns back to nuclear power to tackle energy crisis
  + stars: | 2022-12-16 | by ( ) www.reuters.com   time to read: +2 min
TOKYO, Dec 16 (Reuters) - Japan confirmed a major nuclear power policy shift on Friday to tackle an energy crisis more than a decade after the 2011 Fukushima disaster prompted it to idle most of its reactors. Public opinion has been hostile towards nuclear energy since a massive earthquake and tsunami triggered a meltdown at the Fukushima Daiichi power plant, but the mood has shifted due to soaring energy costs amid the prolonged war in Ukraine and repeated power crunches in both summer and winter. Quake-prone Japan, which previously said it had no plans to build new reactors, will now seek to replace decomissioned ones and extend the lifespan of others, the industry ministry said. Under a strategic energy plan approved by the Cabinet last year, Japan aimed to reduce its dependence on nuclear power as much as possible. Further details will be discussed in parliament next year, an official at the industry ministry said.
U.S. FDA declines to approve Spectrum's lung cancer drug
  + stars: | 2022-11-25 | by ( ) www.reuters.com   time to read: +1 min
Nov 25 (Reuters) - Spectrum Pharmaceuticals Inc (SPPI.O) said on Friday the U.S. Food and Drug Administration (FDA) declined to approve its experimental lung cancer drug due to inadequate data, prompting the drugmaker to cut jobs. The company said it will no longer focus on developing the drug, poziotinib, for treating non-small cell lung cancer (NSCLC) with a rare genetic mutation that affects 2%-4% of the cancer patients. They have fallen 42.5% since an expert panel to the FDA recommended against the drug's approval in September. Nevada-based Spectrum said it will cut 75% of its research and development workforce and focus on its other cancer drug, Rolvedon. Reporting by Khushi Mandowara; Editing by Krishna Chandra Eluri, Shounak Dasgupta and Shinjini GanguliOur Standards: The Thomson Reuters Trust Principles.
Total: 25